Jeffery J. Auletta, MD :: Nationwide Children's Hospital, Columbus, Ohio

Contact Information

Hematology & Oncology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-3550
FX: (614) 722-3369

Location Information for Patients

Main Campus


Dr. Auletta is the Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases (HD) Program at Nationwide Children's Hospital. He is a physician in both Hematology/Oncology/BMT and Infectious Diseases at Nationwide Children’s Hospital. Dr. Auletta is an associate professor of Pediatrics at The Ohio State University College of Medicine. He is a member of the Leukemia Research Program at The NCI-designated Ohio State University Comprehensive Cancer Center and a member of the Center for Regenerative Medicine and Cell-based Therapies at The Ohio State University. Dr. Auletta completed his internship and residency in Pediatrics and his fellowships in both Pediatric Hematology-Oncology and Pediatric Infectious Diseases at University Hospitals and Case Medical Center/Rainbow Babies & Children’s Hospital. He earned his doctor of medicine from Case Western Reserve University School of Medicine and his bachelor of arts from Northwestern University. Dr. Auletta is a member of several professional organizations, including the Children’s Oncology Group (COG), the American Society for Blood and Marrow Transplantation (ASBMT), the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA). He is Co-Chair for the Infection and Immune Reconstitution Working Committee of the Center for International Blood & Marrow Transplant Research (CIBMTR) and for the Supportive Care Committee of the Pediatric Blood and Marrow Transplant Consortium (PBMTC).


  • Male

Languages Spoken:

  • English

Education and Training

Medical School

  • Case Western Reserve University
    Date Completed: 06/30/1996


  • University Hospitals Case Medical Center
    Date Completed: 06/30/1999


  • University Hospitals of Cleveland
    Date Completed: 06/30/2003


  • University Hospitals Case Medical Center
    Date Completed: 06/30/2003


  • Pediatrics


  • Hematology & Oncology


  • Pediatric Hematology Oncology
  • Pediatric Infectious Diseases
  • Pediatrics

Date of Appointment at Nationwide Children’s Hospital:

  • 12/03/2012


  • Gonzalez B, Cabral l Auletta JJ. 2015. A Practical Evidence-based Guidelines. In Supportive Care in Pediatric Oncology. Edited by Feusner J, Hastings C, Agrawal AK. New York: Springer Berlin Heidelberg.
  • Auletta JJ. 2010. Antifungal Therapy. In The Immune respopnse o fungal challenge. Edited by Perfect J, Ghannoum M.. New York: Informal Healthcare.
  • Maziarz RT, Brazauskas B, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Leee JW, Liesveld JL, Ramanathan M, Redy V, Savani BN, Smith FO, Strasfeld L, Taplitz Ra, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. Pre-Existing invasive fungal 8infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.  Bone Marrow Transplant.
  • Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn K, Chen M, Green J, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ. Early CMV reactivation increases transplant-related mortality without attenuating hematologic disease relapse risk following allogeneic hematopoietic cell transplantation: a CIBMTR study.  Blood.
  • Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn K, Chen M, Green J, Saad A, Seftel M, Saber W, Svani B, Waller E, Wingard JR, Auletta JJ, Lindemans CA, Boeckh M, Riches ML. Impact of early cytomegaloviru8s reactivation in cor blood stem cell recipents in the current era.  Bone Marrow Transplant.
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000